Actively Recruiting

Phase 3
Age: 55Years - 90Years
All Genders
NCT05511363

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

Led by Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Updated on 2026-05-04

410

Participants Needed

116

Research Sites

214 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a Phase 3, 38-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with psychosis associated with Alzheimer's Disease. The primary objective of the study is to evaluate relapse prevention in subjects with psychosis associated with Alzheimer's Disease treated with KarXT compared to placebo. The secondary objectives of the study are to evaluate the time from randomization to discontinuation for any reason or relapse and safety and tolerability in subjects with psychosis associated with Alzheimer's Disease treated with KarXT compared to placebo.

CONDITIONS

Official Title

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

Who Can Participate

Age: 55Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 55 to 90 years at screening
  • Able to understand the study and provide informed consent, or have a legally acceptable representative provide consent
  • Meet clinical criteria for possible or probable Alzheimer's Disease
  • Have a brain MRI or CT scan within the past 5 years to rule out other central nervous system diseases, or complete one during screening
  • Living at the same location for at least 4 weeks before screening and intend to stay there during the study
  • Able to move independently or with assistance and have an identified caregiver or study partner with frequent contact (at least 10 hours per week) who can attend visits and help with compliance
  • History of psychotic symptoms meeting International Psychogeriatric Association criteria for at least 2 months before screening
  • Clinical Global Impressions-Severity scale score of 4 or higher at screening and baseline
  • Meet criteria for moderate to severe delusions or hallucinations based on Neuropsychiatric Inventory-Clinician scores at screening and baseline
  • Mini-Mental State Examination score between 6 and 24 at screening
  • If taking cholinesterase inhibitors or memantine, stable dose for at least 6 weeks before screening and willing to maintain during study
  • Willing and able to attend outpatient clinic visits and follow study instructions
  • Body mass index between 16 and 40 kg/m2
  • Female participants must not be pregnant or breastfeeding, and women of childbearing potential and their male partners must use effective contraception during and for at least 30 days after the study
Not Eligible

You will not qualify if you...

  • Psychotic symptoms primarily due to conditions other than Alzheimer's Disease
  • History of major depressive episode with psychotic features within 12 months before screening
  • History of bipolar disorder, schizophrenia, or schizoaffective disorder
  • Significant or severe medical conditions that could affect safety or study participation, including pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, cardiovascular, or cancer-related diseases
  • Severe kidney impairment with estimated glomerular filtration rate below 50 mL/min
  • History of ischemic stroke within 12 months or any hemorrhagic stroke
  • History of cerebral amyloid angiopathy, epilepsy, CNS tumors, unstable thyroid function, or unexplained fainting
  • Certain heart conditions including congestive heart failure class 2, angina grade 2 or higher, sustained ventricular arrhythmias, implantable defibrillator, or recent myocardial infarction
  • Personal or family history of long QT syndrome
  • HIV infection, liver diseases or active liver infections
  • History or high risk of urinary retention, gastric retention, or narrow-angle glaucoma
  • History of bladder stones or recurrent urinary tract infections
  • For male participants: high prostate-specific antigen levels or severe urinary symptoms
  • History of obstructive gastrointestinal disorders or serious constipation requiring treatment in past 6 months
  • Risk of suicidal behavior during the study
  • Significant abnormal findings on physical exam, ECG, or lab tests
  • Positive urine test for substances (except limited cannabis or benzodiazepines use with approval)
  • Use of certain psychoactive medications unless stable or able to wash out
  • Unsuitable for enrollment due to safety or compliance concerns
  • Positive COVID-19 test within 2 weeks before or at screening
  • Unable to discontinue medications that prevent study participation
  • Prior exposure to KarXT or adverse reactions to trospium
  • Participation in other clinical studies involving experimental drugs within 3 months or more than 2 studies in past year

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 116 locations

1

Local Institution - 1029

Homewood, Alabama, United States, 35209-6809

Active, Not Recruiting

2

Local Institution - 1044

Phoenix, Arizona, United States, 85012-2836

Completed

3

Local Institution - 1033

Encino, California, United States, 91436-2201

Completed

4

Local Institution - 1031

Irvine, California, United States, 92612-1246

Withdrawn

5

ATP Clinical Research-302 W La Veta Ave

Orange, California, United States, 92866

Actively Recruiting

6

Local Institution - 1043

Pasadena, California, United States, 91106

Completed

7

Local Institution - 1047

San Marcos, California, United States, 92069-3595

Completed

8

Sunwise Clinical Research, LLC - Walnut Creek - IVY - PPDS

Walnut Creek, California, United States, 94596

Actively Recruiting

9

Local Institution - 1014

Colorado Springs, Colorado, United States, 80907-5302

Completed

10

Local Institution - 1013

Stamford, Connecticut, United States, 06905-1206

Completed

11

Local Institution - 1011

Boca Raton, Florida, United States, 33487-2768

Completed

12

Envision Trials LLC

Bonita Springs, Florida, United States, 34134

Actively Recruiting

13

Local Institution - 1015

Bradenton, Florida, United States, 34209-4687

Completed

14

K2 Medical Research - Winter Garden

Clermont, Florida, United States, 34711-5933

Actively Recruiting

15

Arrow Clinical Trials

Daytona Beach, Florida, United States, 32117-5532

Actively Recruiting

16

Local Institution - 1045

Doral, Florida, United States, 33172-2638

Active, Not Recruiting

17

Local Institution - 1046

Hialeah, Florida, United States, 33012-5826

Active, Not Recruiting

18

Local Institution - 1024

Hialeah, Florida, United States, 33012-5884

Withdrawn

19

Local Institution - 1052

Hialeah, Florida, United States, 33012

Active, Not Recruiting

20

Local Institution - 1049

Homestead, Florida, United States, 33032

Active, Not Recruiting

21

K2 Medical Research - Maitland

Maitland, Florida, United States, 32751-5669

Actively Recruiting

22

Local Institution - 1021

Miami, Florida, United States, 33122-1335

Active, Not Recruiting

23

Local Institution - 1005

Miami, Florida, United States, 33125-3724

Completed

24

Local Institution - 1115

Miami, Florida, United States, 33135

Active, Not Recruiting

25

Local Institution - 1010

Miami, Florida, United States, 33137

Completed

26

Local Institution - 1143

Miami, Florida, United States, 33145-2455

Completed

27

Local Institution - 1009

Miami, Florida, United States, 33155-4630

Active, Not Recruiting

28

Local Institution - 1129

Miami, Florida, United States, 33165-3947

Active, Not Recruiting

29

Local Institution - 1053

Miami, Florida, United States, 33166

Active, Not Recruiting

30

Local Institution - 1006

Miami, Florida, United States, 33173-1474

Active, Not Recruiting

31

Local Institution - 1111

Miami, Florida, United States, 33173

Active, Not Recruiting

32

Local Institution - 1054

Miami, Florida, United States, 33186-4643

Active, Not Recruiting

33

Local Institution - 1042

Miami, Florida, United States, 33186-5882

Active, Not Recruiting

34

Local Institution - 1032

Miami Lakes, Florida, United States, 33014-5602

Active, Not Recruiting

35

Local Institution - 1026

Miami Springs, Florida, United States, 33166-5260

Active, Not Recruiting

36

Local Institution - 1027

Ocala, Florida, United States, 34470-6657

Withdrawn

37

Local Institution - 1012

Pensacola, Florida, United States, 32504-8608

Completed

38

Local Institution - 1008

St. Petersburg, Florida, United States, 33713-8844

Active, Not Recruiting

39

University of South Florida

Tampa, Florida, United States, 33606

Actively Recruiting

40

Local Institution - 1041

Tampa, Florida, United States, 33607-4629

Completed

41

Local Institution - 1040

The Villages, Florida, United States, 32159-8986

Withdrawn

42

Local Institution - 1037

Chicago, Illinois, United States, 60623

Completed

43

Local Institution - 1018

Manhasset, New York, United States, 11030-3816

Active, Not Recruiting

44

Local Institution - 1030

New York, New York, United States, 10016

Withdrawn

45

Local Institution - 1051

New York, New York, United States, 10032-3720

Completed

46

Local Institution - 1017

New York, New York, United States, 10032

Completed

47

Local Institution - 1002

Staten Island, New York, United States, 10314-1607

Active, Not Recruiting

48

Local Institution - 1034

Stony Brook, New York, United States, 11794-0001

Completed

49

Five Towns Neurology, PC

Woodmere, New York, United States, 11598-1739

Actively Recruiting

50

Local Institution - 1003

Canton, Ohio, United States, 44718

Withdrawn

51

Local Institution - 1028

Oklahoma City, Oklahoma, United States, 73104-5007

Withdrawn

52

Local Institution - 1016

Oklahoma City, Oklahoma, United States, 73112

Completed

53

Local Institution - 1019

Allentown, Pennsylvania, United States, 18103

Completed

54

Local Institution - 1035

Charleston, South Carolina, United States, 29425-8900

Completed

55

Local Institution - 1038

Franklin, Tennessee, United States, 37067-5922

Completed

56

Local Institution - 1022

Flower Mound, Texas, United States, 75028-2011

Completed

57

Local Institution - 1036

Frisco, Texas, United States, 75034-6262

Completed

58

Clinical Trial Network - 7080 Southwest Fwy

Houston, Texas, United States, 77074-2085

Actively Recruiting

59

Medical Center Sveti Naum EOOD

Sofia, Sofia-Grad, Bulgaria, 1113

Actively Recruiting

60

Local Institution - 4505

Sofia, Sofia-Grad, Bulgaria, 1431

Completed

61

Local Institution - 4502

Sofia, Sofia-Grad, Bulgaria, 1510

Completed

62

Medical Center Medconsult Pleven OOD

Pleven, Bulgaria, 5800

Actively Recruiting

63

Local Institution - 4504

Vratsa, Bulgaria, 3000

Completed

64

Local Institution - 4103

Zagreb, City of Zagreb, Croatia, 10000

Completed

65

Local Institution - 4105

Zagreb, City of Zagreb, Croatia, 10000

Active, Not Recruiting

66

Polyclinic Neuron

Zagreb, City of Zagreb, Croatia, 10000

Actively Recruiting

67

Local Institution - 4101

Zagreb, City of Zagreb, Croatia, 10090

Active, Not Recruiting

68

Psychiatric Clinic Sveti Ivan

Zagreb, City of Zagreb, Croatia, 10090

Actively Recruiting

69

CLINTRIAL s.r.o.

Prague, Praha, Hlavní Mesto, Czechia, 100 00

Actively Recruiting

70

Local Institution - 4003

Brno, South Moravian, Czechia, 628 00

Withdrawn

71

Local Institution - 4001

Kutná Hora, Czechia, 284 01

Completed

72

A-SHINE s.r.o.

Pilsen, Czechia, 301 00

Actively Recruiting

73

Local Institution - 4004

Prague, Czechia, 140 00

Completed

74

Vestra Clinics s.r.o.

Rychnov nad Kněžnou, Czechia, 516 01

Actively Recruiting

75

Local Institution - 2501

Reims, Marne, France, 51100

Active, Not Recruiting

76

Local Institution - 2502

Dijon, France, 21079

Active, Not Recruiting

77

Local Institution - 2503

Rouen, France, 76000

Completed

78

Local Institution - 2401

Böblingen, Baden-Wurttemberg, Germany, 71034

Completed

79

Local Institution - 2403

Bayreuth, Bavaria, Germany, 95445

Withdrawn

80

Local Institution - 2402

Homburg, Saarland, Germany, 66424

Withdrawn

81

Local Institution - 2301

Rome, Lazio, Italy, 00179

Completed

82

Azienda Ospedaliero-Universitaria di Modena - Policlinico di Modena

Baggiovara, Modena, Italy, 41126

Actively Recruiting

83

Local Institution - 2307

Ponderano (Biella), Piedmont, Italy, 13875

Active, Not Recruiting

84

Local Institution - 2308

Florence, Tuscany, Italy, 50139

Completed

85

Local Institution - 2304

Milan, Italy, 20121

Completed

86

Local Institution - 2305

Monza, Italy, 20900

Completed

87

Local Institution - 2302

Pisa, Italy, 56126

Completed

88

Local Institution - 2303

Roma, Italy, 00168

Active, Not Recruiting

89

Local Institution - 2309

Roma, Italy, 00189

Completed

90

University Clinical Center of Serbia - Pasterova 2 - PPDS

Belgrade, Belgrade, Serbia, 11000

Actively Recruiting

91

Clinical Hospital Center Dragisa Misovic Dedinje

Belgrade, Serbia, 11000

Actively Recruiting

92

Local Institution - 4307

Belgrade, Serbia, 11000

Completed

93

Military Medical Academy

Belgrade, Serbia, 11000

Actively Recruiting

94

Military Medical Academy

Belgrade, Serbia, 11000

Actively Recruiting

95

Local Institution - 4305

Kovin, Serbia, 26220

Completed

96

University Clinical Center Kragujevac

Kragujevac, Serbia, 34000

Actively Recruiting

97

University Clinical Center Kragujevac

Kragujevac, Serbia, 34000

Actively Recruiting

98

University Clinical Center Kragujevac

Kragujevac, Serbia, 34000

Actively Recruiting

99

Clinical Centre of Vojvodina

Novi Sad, Serbia, 21000

Actively Recruiting

100

Local Institution - 4311

Vršac, Serbia, 26300

Completed

101

Univerzitna nemocnica L Pasteura Kosice-Rastislavova 43

Košice, Košice Region, Slovakia, 041 90

Actively Recruiting

102

MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.

Banská Bystrica, Slovakia, 974 04

Actively Recruiting

103

KONZILIUM s.r.o

Dubnica nad Váhom, Slovakia, 018 41

Actively Recruiting

104

EPAMED s.r.o

Košice, Slovakia, 040 01

Actively Recruiting

105

Crystal Comfort, s.r.o.

Vranov nad Topľou, Slovakia, 093 01

Actively Recruiting

106

Local Institution - 4404

Žilina, Slovakia, 012 07

Withdrawn

107

Local Institution - 2205

Barcelona, Spain, 8028

Completed

108

Local Institution - 2207

Madrid, Spain, 28006

Completed

109

Complejo Asistencial Universitario de Salamanca - H. Clinico

Salamanca, Spain, 37007

Actively Recruiting

110

Hospital Victoria Eugenia

Seville, Spain, 41009

Actively Recruiting

111

Hospital Universitario Rio Hortega

Valladolid, Spain, 47012

Actively Recruiting

112

Hospital Provincial de Zamora

Zamora, Spain, 49021

Actively Recruiting

113

Hospital Viamed Montecanal

Zaragoza, Spain, 50012

Actively Recruiting

114

Local Institution - 2103

Swindon, Wiltshire, United Kingdom, SN3 6BW

Withdrawn

115

Local Institution - 2105

Aberdeen, United Kingdom, AB25 2ZL

Withdrawn

116

Local Institution - 2104

Motherwell, United Kingdom, ML1 4UF

Withdrawn

Loading map...

Research Team

B

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com

CONTACT

F

First line of the email MUST contain NCT # and Site #.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here